Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-EN Version v6-EN
Language English English
Date Updated 2018-08-15 2018-01-19
Drug Identification Number 02274566 02274566
Brand name GD-AZITHROMYCIN GD-AZITHROMYCIN
Common or Proper name AZITHROMYCIN AZITHROMYCIN
Company Name GENMED A DIVISION OF PFIZER CANADA ULC GENMED A DIVISION OF PFIZER CANADA ULC
Ingredients AZITHROMYCIN AZITHROMYCIN
Strength(s) 100MG 100MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 300mg/15mL 300mg/15mL
ATC code J01FA J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-01-17 2018-01-17
Estimated end date 2018-03-15
Actual end date 2018-08-14
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments